首页> Journal of clinical oncology : official journal of the American Society of Clinical Oncology> Clonal MET Amplification as a Determinant of Tyrosine Kinase Inhibitor Resistance in Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer.

Clonal MET Amplification as a Determinant of Tyrosine Kinase Inhibitor Resistance in Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer.

导出原文传递

翻译打印收藏纠错

第一作者： Gillianne G Y,Lai

第一单位： 1 National Cancer Centre Singapore, Singapore.

作者： Gillianne G Y,Lai ^[1] ; Tse Hui,Lim ^[2] ; John,Lim ^[1] ; Perry J R,Liew ^[2] ; Xue Lin,Kwang ^[1] ; Rahul,Nahar ^[3] ; Zaw Win,Aung ^[1] ; Angela,Takano ^[2] ; Yin Yeng,Lee ^[3] ; Dawn P X,Lau ^[1] ; Gek San,Tan ^[2] ; Sze Huey,Tan ^[1] ; Wan Ling,Tan ^[1] ; Mei-Kim,Ang ^[1] ; Chee Keong,Toh ^[1] ; Bien Soo,Tan ^[2] ; Anantham,Devanand ^[2] ; Chow Wei,Too ^[2] ; Apoorva,Gogna ^[2] ; Boon Hean,Ong ^[4] ; Tina P T,Koh ^[1] ; Ravindran,Kanesvaran ^[1] ; Quan Sing,Ng ^[1] ; Amit,Jain ^[1] ; Tanujaa,Rajasekaran ^[1] ; Ju,Yuan ^[3] ; Tony Kiat Hon,Lim ^[2] ; Alvin S T,Lim ^[2] ; Axel M,Hillmer ^[3] ; Wan Teck,Lim ^[1] ; N Gopalakrishna,Iyer ^[1] ; Wai Leong,Tam ^[3] ; Weiwei,Zhai ^[3] ; Eng-Huat,Tan ^[1] ; Daniel S W,Tan ^[5]

作者单位： 1 National Cancer Centre Singapore, Singapore. ^[1] 2 Singapore General Hospital, Singapore. ^[2] 3 Genome Institute of Singapore, Singapore. ^[3] 4 National Heart Centre Singapore, Singapore. ^[4] 1 National Cancer Centre Singapore, Singapore.;3 Genome Institute of Singapore, Singapore. ^[5]